Reports of ocular adverse reactions.
D000700:Analgesics / Q000009:adverse effects; D000777:Anesthetics / Q000009:adverse effects; D000890:Anti-Infective Agents / Q000009:adverse effects; D000927:Anticonvulsants / Q000009:adverse effects; D002386:Cataract / Q000139:chemically induced; D003231:Conjunctivitis / Q000139:chemically induced; D003276:Contraceptives, Oral / Q000009:adverse effects; D004172:Diplopia / Q000139:chemically induced; D005128:Eye Diseases / Q000139:chemically induced*; D005901:Glaucoma / Q000139:chemically induced; D006728:Hormones / Q000009:adverse effects; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects; D007880:Legislation, Drug; D009902:Optic Neuritis / Q000139:chemically induced; D010276:Parasympatholytics / Q000009:adverse effects; D010277:Parasympathomimetics / Q000009:adverse effects; D012173:Retinitis / Q000139:chemically induced; D013565:Sympatholytics / Q000009:adverse effects; D013566:Sympathomimetics / Q000009:adverse effects; D014149:Tranquilizing Agents / Q000009:adverse effects; D006113:United Kingdom; D014612:Vaccines / Q000009:adverse effects; D014786:Vision Disorders / Q000139:chemically induced*
D000700:Analgesics; D000777:Anesthetics; D000890:Anti-Infective Agents; D000927:Anticonvulsants; D003276:Contraceptives, Oral; D006728:Hormones; D006993:Hypnotics and Sedatives; D010276:Parasympatholytics; D010277:Parasympathomimetics; D013565:Sympatholytics; D013566:Sympathomimetics; D014149:Tranquilizing Agents; D014612:Vaccines